Related Experiment Video
Updated: Feb 28, 2026

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
Published on: February 6, 2021
Malignant Syndrome or Withdrawal Reaction?
Wenzheng Wang1, Hui Wen1, Jianhua Sheng1
1Shanghai Key Laboratory of Major Mental Health Disorder, Shanghai Mental Health Center, Shanghai Jiao Tong University Medical College, Shanghai, China.
Abstract:
We report on a case of a female patient who had serious side effects from treatment with clozapine and chlorpromazine and the appeared to have a withdrawal reaction from cessation of clozapine. During the treatment process she was misdiagnosed as having malignant syndrome. This case highlights the importance of clinicians being able to distinguish malignant syndrome from withdrawal reactions, and to be familiar with treatment and prevention methods for both.
More Related Videos
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
18:01Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 18, 2008
Related Concept Videos
Toxidromes: Clinical Features
Drug toxicity: Idiosyncratic Reactions
Desensitization and Tachyphylaxis
Drug Toxicity: Allergic Reactions
Mania and Antimanic Drugs: Overview
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...